DarioHealth (NASDAQ:DRIO) Cut to Hold at TD Cowen

TD Cowen cut shares of DarioHealth (NASDAQ:DRIO) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning, Marketbeat.com reports. They currently have $1.00 price objective on the stock, down from their previous price objective of $2.00.

DarioHealth Trading Down 3.1 %

NASDAQ:DRIO opened at $0.62 on Wednesday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.32 and a current ratio of 1.57. DarioHealth has a 1 year low of $0.56 and a 1 year high of $2.60. The stock has a market capitalization of $21.14 million, a price-to-earnings ratio of -0.66 and a beta of 1.39. The stock has a fifty day moving average price of $0.76 and a two-hundred day moving average price of $0.89.

DarioHealth (NASDAQ:DRIO) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07). DarioHealth had a negative return on equity of 72.16% and a negative net margin of 205.62%. The firm had revenue of $7.42 million during the quarter, compared to analyst estimates of $7.34 million. During the same quarter in the prior year, the company earned ($0.49) EPS. As a group, sell-side analysts anticipate that DarioHealth will post -1.18 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DarioHealth

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. XTX Topco Ltd grew its holdings in shares of DarioHealth by 81.4% during the third quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after buying an additional 13,219 shares in the last quarter. Appian Way Asset Management LP boosted its position in DarioHealth by 2.5% during the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after acquiring an additional 34,990 shares during the last quarter. Finally, DLK Investment Management LLC grew its stake in DarioHealth by 40.9% in the 4th quarter. DLK Investment Management LLC now owns 141,657 shares of the company’s stock worth $111,000 after acquiring an additional 41,107 shares during the period. Hedge funds and other institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.